Skip to main content
HNGE logo

HNGE · Hinge Health, Inc.

Track HNGE — free
$87.47 -1.02 (-1.15%)
Market Cap
$7.14B
Shares
80.69M

Hinge Health, Inc. Earnings Call Transcripts

Every quarterly earnings call for Hinge Health, Inc. (HNGE) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-04
Hinge Health Q2 2026 Earnings Call
Confident tone Migraine care program expansion Q2 financial performance and profitability Sales pipeline and win rates
Revenue
$212.82M
▲ 53% YoY
Diluted EPS
$0.52
Gross margin
86.4%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-05
Hinge Health, Inc. Q1 FY2026 Earnings Call
Confident tone Quarterly financial performance Commercial pipeline and sales cycle ENSO device distribution and unit economics
Revenue
$182.31M
▲ 47.2% YoY
Diluted EPS
$0.41
▼ 68.7% YoY
Gross margin
84.6%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-10
Hinge Health, Inc. Q4 FY2025 Earnings Call
Confident tone Financial performance and growth Hinge Select provider network Market expansion and penetration
Revenue
$170.73M*
Gross margin
84.4%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Hinge Health, Inc. Q3 FY2025 Earnings Call
Confident tone Revenue and growth Profitability and cash flow Hinge Select expansion
Revenue
$154.21M
▲ 53.3% YoY
Diluted EPS
$-0.02
▼ 300% YoY
Gross margin
81.8%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Hinge Health, Inc. Q2 FY2025 Earnings Call
Confident tone Revenue and growth Market opportunity and TAM Channel partnerships and go-to-market
Revenue
$139.10M
▲ 54.9% YoY
Diluted EPS
$-13.10
Gross margin
70.3%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–5 of 5 earnings calls
Key facts CIK 1673743 CUSIP 433313103 13F (30d) 275 filings 274 filers Visit website Investor relations